Literature DB >> 10579114

Oral infections and other manifestations of HIV disease.

L L Patton1, C van der Horst.   

Abstract

Oral lesions are important in the clinical spectrum of HIV/AIDS, arousing suspicion of acute seroconversion illness (aphthous ulceration and candidiasis), suggesting HIV infection in the undiagnosed individual (candidiasis, hairy leukoplakia, Kaposi's sarcoma, necrotizing ulcerative gingivitis), indicating clinical disease progression and predicting development of AIDS (candidiasis, hairy leukoplakia), and marking immune suppression in HIV-infected individuals (candidiasis, hairy leukoplakia, necrotizing periodontal disease, Kaposi's sarcoma, long-standing herpes infection, major aphthous ulcers). In addition, oral lesions are included in staging systems for HIV disease progression and as entry criteria or endpoints in clinical trials of antiretroviral drugs. Recognition and management of these oral conditions is important for the health and quality of life of the individual with HIV/AIDS. In keeping with this, the U.S. Department of Health Services Clinical Practice Guideline for Evaluation and Management of Early HIV Infection includes recommendations that an oral examination, emphasizing oral mucosal surfaces, be conducted by the primary care provider at each visit, a dental examination by a dentist should be done at least two times a year, and patients should be informed of the importance of oral care and educated about common HIV-related oral lesions and associated symptoms.

Entities:  

Mesh:

Year:  1999        PMID: 10579114     DOI: 10.1016/s0891-5520(05)70114-8

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  11 in total

Review 1.  Selected topics on lymphoid lesions in the head and neck regions.

Authors:  Wesley O Greaves; Sa A Wang
Journal:  Head Neck Pathol       Date:  2011-02-03

Review 2.  Viruses and salivary gland disease (SGD): lessons from HIV SGD.

Authors:  L Jeffers; J Y Webster-Cyriaque
Journal:  Adv Dent Res       Date:  2011-04

3.  Management algorithm for HIV-associated parotid lymphoepithelial cysts.

Authors:  Waleed F Mourad; Shyamal Patel; Rebekah Young; Azita S Khorsandi; Catherine Concert; Rania A Shourbaji; Katherine Ciarrocca; Richard L Bakst; Daniel Shasha; Chandan Guha; Madhur K Garg; Kenneth S Hu; Shalom Kalnicki; Louis B Harrison
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

4.  Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system.

Authors:  Liesl K Jeffers-Francis; Raquel Burger-Calderon; Jennifer Webster-Cyriaque
Journal:  Antiviral Res       Date:  2015-03-16       Impact factor: 5.970

5.  Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan.

Authors:  Mohammad H Al-Shayyab; Osama A Abu-Hammad; Mahmoud K Al-Omiri; Najla S Dar-Odeh
Journal:  Int Dent J       Date:  2015-07-07       Impact factor: 2.607

6.  Exposure of dentists to Mycobacterium tuberculosis, Ibadan, Nigeria.

Authors:  Simeon I Cadmus; Victoria N Okoje; Babafemi O Taiwo; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2010-09       Impact factor: 6.883

7.  First report of HIV-related oral manifestations in Mali.

Authors:  Irene Tamí-Maury; Yaya Ibrahim Coulibaly; Souare Salimata Cissoko; Sounkalo Dao; Sibylle Kristensen
Journal:  Pan Afr Med J       Date:  2012-01-31

8.  Oral lesions associated with HIV/AIDS in HIV-seropositive patients attending a counselling and treatment centre in Dar es Salaam.

Authors:  Ibrahim E A T Mwangosi; Jackline Tillya
Journal:  Int Dent J       Date:  2012-06-14       Impact factor: 2.607

9.  Significant Depletion of CD4(+) T Cells Occurs in the Oral Mucosa during Simian Immunodeficiency Virus Infection with the Infected CD4(+) T Cell Reservoir Continuing to Persist in the Oral Mucosa during Antiretroviral Therapy.

Authors:  Jeffy George; Wendeline Wagner; Mark G Lewis; Joseph J Mattapallil
Journal:  J Immunol Res       Date:  2015-04-30       Impact factor: 4.818

10.  Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans-In Silico, In Vitro and In Vivo Approaches.

Authors:  André L S Santos; Lys A Braga-Silva; Diego S Gonçalves; Lívia S Ramos; Simone S C Oliveira; Lucieri O P Souza; Vanessa S Oliveira; Roberto D Lins; Marcia R Pinto; Julian E Muñoz; Carlos P Taborda; Marta H Branquinha
Journal:  J Fungi (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.